{"name": "Antisense Pharma",
 "permalink": "antisense-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/antisense-pharma",
 "homepage_url": "http://www.antisense-pharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "antisense, antisense-gene-splicing, german-biopharma",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "German BioPharma Company",
 "created_at": "Tue Apr 06 06:56:04 UTC 2010",
 "updated_at": "Fri Jan 27 04:21:48 UTC 2012",
 "overview": "\u003Cp\u003EAnitsense Pharma a clinical-stage biopharmaceutical company focused on antisense gene silencing for pancreatic cancer, malignant melanoma and colorectal cancer\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[107,
       33],
      "assets/images/resized/0008/2949/82949v2-max-150x150.png"],
     [[107,
       33],
      "assets/images/resized/0008/2949/82949v2-max-250x250.png"],
     [[107,
       33],
      "assets/images/resized/0008/2949/82949v2-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$36.5M",
 "funding_rounds":
  [{"round_code": "e",
    "source_url": "http://onbiovc.com/antisense-pharma-gmbh-series-e-175m/",
    "source_description": "Antisense Pharma, GmbH: Series E $17.5M ",
    "raised_amount": 17500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MIG AG",
         "permalink": "mig-ag",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0006/1641/61641v1-max-150x150.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-250x250.png"],
             [[213,
               71],
              "assets/images/resized/0006/1641/61641v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Global Asset Fund",
         "permalink": "global-asset-fund",
         "image":
          {"available_sizes":
            [[[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-150x150.jpg"],
             [[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-250x250.jpg"],
             [[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/07/antisense-pharma-receives-e8m-mig-funds-gaf.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Antisense Pharma Receives \u00e2\u201a\u00ac8M from MIG Funds and GAF",
    "raised_amount": 8000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 7,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MIG Funds",
         "permalink": "mig-funds",
         "image": null},
       "person": null}]},
   {"round_code": "f",
    "source_url": "http://onbiovc.com/antisense-pharma-gmbh-series-f-11m/",
    "source_description": "Antisense Pharma, GmbH: Series F $11M",
    "raised_amount": 11000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 1,
    "funded_day": 26,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MIG Fonds",
         "permalink": "mig-fonds",
         "image":
          {"available_sizes":
            [[[150,
               64],
              "assets/images/resized/0025/8902/258902v1-max-150x150.png"],
             [[165,
               71],
              "assets/images/resized/0025/8902/258902v1-max-250x250.png"],
             [[165,
               71],
              "assets/images/resized/0025/8902/258902v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Global Asset Fund",
         "permalink": "global-asset-fund",
         "image":
          {"available_sizes":
            [[[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-150x150.jpg"],
             [[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-250x250.jpg"],
             [[103,
               52],
              "assets/images/resized/0010/2182/102182v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "Josef-Engert-Str. 9 ",
    "address2": "",
    "zip_code": "93053",
    "city": "Regensburg",
    "state_code": null,
    "country_code": "DEU",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}